Cargando…

Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations

Marine and freshwater algae and their products are in growing demand worldwide because of their nutritional and functional properties. Microalgae (unicellular algae) will constitute one of the major foods of the future for nutritional and environmental reasons. They are sources of high-quality prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Romero, Sara, Torrella, Joan Ramon, Pagès, Teresa, Viscor, Ginés, Torres, Josep Lluís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916042/
https://www.ncbi.nlm.nih.gov/pubmed/33572056
http://dx.doi.org/10.3390/nu13020563
_version_ 1783657388488785920
author Ramos-Romero, Sara
Torrella, Joan Ramon
Pagès, Teresa
Viscor, Ginés
Torres, Josep Lluís
author_facet Ramos-Romero, Sara
Torrella, Joan Ramon
Pagès, Teresa
Viscor, Ginés
Torres, Josep Lluís
author_sort Ramos-Romero, Sara
collection PubMed
description Marine and freshwater algae and their products are in growing demand worldwide because of their nutritional and functional properties. Microalgae (unicellular algae) will constitute one of the major foods of the future for nutritional and environmental reasons. They are sources of high-quality protein and bioactive molecules with potential application in the modern epidemics of obesity and diabetes. They may also contribute decisively to sustainability through carbon dioxide fixation and minimization of agricultural land use. This paper reviews current knowledge of the effects of consuming edible microalgae on the metabolic alterations known as metabolic syndrome (MS). These microalgae include Chlorella, Spirulina (Arthrospira) and Tetraselmis as well as Isochrysis and Nannochloropsis as candidates for human consumption. Chlorella biomass has shown antioxidant, antidiabetic, immunomodulatory, antihypertensive, and antihyperlipidemic effects in humans and other mammals. The components of microalgae reviewed suggest that they may be effective against MS at two levels: in the early stages, to work against the development of insulin resistance (IR), and later, when pancreatic -cell function is already compromised. The active components at both stages are antioxidant scavengers and anti-inflammatory lipid mediators such as carotenoids and -3 PUFAs (eicosapentaenoic acid/docosahexaenoic acid; EPA/DHA), prebiotic polysaccharides, phenolics, antihypertensive peptides, several pigments such as phycobilins and phycocyanin, and some vitamins, such as folate. As a source of high-quality protein, including an array of bioactive molecules with potential activity against the modern epidemics of obesity and diabetes, microalgae are proposed as excellent foods for the future. Moreover, their incorporation into the human diet would decisively contribute to a more sustainable world because of their roles in carbon dioxide fixation and reducing the use of land for agricultural purposes.
format Online
Article
Text
id pubmed-7916042
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79160422021-03-01 Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations Ramos-Romero, Sara Torrella, Joan Ramon Pagès, Teresa Viscor, Ginés Torres, Josep Lluís Nutrients Review Marine and freshwater algae and their products are in growing demand worldwide because of their nutritional and functional properties. Microalgae (unicellular algae) will constitute one of the major foods of the future for nutritional and environmental reasons. They are sources of high-quality protein and bioactive molecules with potential application in the modern epidemics of obesity and diabetes. They may also contribute decisively to sustainability through carbon dioxide fixation and minimization of agricultural land use. This paper reviews current knowledge of the effects of consuming edible microalgae on the metabolic alterations known as metabolic syndrome (MS). These microalgae include Chlorella, Spirulina (Arthrospira) and Tetraselmis as well as Isochrysis and Nannochloropsis as candidates for human consumption. Chlorella biomass has shown antioxidant, antidiabetic, immunomodulatory, antihypertensive, and antihyperlipidemic effects in humans and other mammals. The components of microalgae reviewed suggest that they may be effective against MS at two levels: in the early stages, to work against the development of insulin resistance (IR), and later, when pancreatic -cell function is already compromised. The active components at both stages are antioxidant scavengers and anti-inflammatory lipid mediators such as carotenoids and -3 PUFAs (eicosapentaenoic acid/docosahexaenoic acid; EPA/DHA), prebiotic polysaccharides, phenolics, antihypertensive peptides, several pigments such as phycobilins and phycocyanin, and some vitamins, such as folate. As a source of high-quality protein, including an array of bioactive molecules with potential activity against the modern epidemics of obesity and diabetes, microalgae are proposed as excellent foods for the future. Moreover, their incorporation into the human diet would decisively contribute to a more sustainable world because of their roles in carbon dioxide fixation and reducing the use of land for agricultural purposes. MDPI 2021-02-09 /pmc/articles/PMC7916042/ /pubmed/33572056 http://dx.doi.org/10.3390/nu13020563 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ramos-Romero, Sara
Torrella, Joan Ramon
Pagès, Teresa
Viscor, Ginés
Torres, Josep Lluís
Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations
title Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations
title_full Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations
title_fullStr Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations
title_full_unstemmed Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations
title_short Edible Microalgae and Their Bioactive Compounds in the Prevention and Treatment of Metabolic Alterations
title_sort edible microalgae and their bioactive compounds in the prevention and treatment of metabolic alterations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916042/
https://www.ncbi.nlm.nih.gov/pubmed/33572056
http://dx.doi.org/10.3390/nu13020563
work_keys_str_mv AT ramosromerosara ediblemicroalgaeandtheirbioactivecompoundsinthepreventionandtreatmentofmetabolicalterations
AT torrellajoanramon ediblemicroalgaeandtheirbioactivecompoundsinthepreventionandtreatmentofmetabolicalterations
AT pagesteresa ediblemicroalgaeandtheirbioactivecompoundsinthepreventionandtreatmentofmetabolicalterations
AT viscorgines ediblemicroalgaeandtheirbioactivecompoundsinthepreventionandtreatmentofmetabolicalterations
AT torresjoseplluis ediblemicroalgaeandtheirbioactivecompoundsinthepreventionandtreatmentofmetabolicalterations